We found that HIF-1α silencing significantly decreased the proliferation rate of the irradiated glioma cells whereas HIF-1α overexpression had the opposite effect, which confirmed the crucial role of HIF-1α in the response to radiotherapy. The gene discussed is HIF1A; the disease is glioma.